Subtopic Deep Dive

Pharmacotherapy Optimization
Research Guide

What is Pharmacotherapy Optimization?

Pharmacotherapy Optimization is the systematic refinement of drug dosing, combinations, and patient-specific regimens using pharmacokinetic modeling, adherence assessment, and clinical evidence to maximize efficacy and minimize adverse effects.

This subtopic integrates clinical trial data, real-world electronic health records, and pharmacokinetic simulations. Key studies address adherence in hypertension (Shuper et al., 2020; Ryvak et al., 2017) and therapy management (Eukel et al., 2010, 26 citations). Over 10 papers from 2010-2023 focus on chronic diseases and pandemics, with Шаповалова (2022) leading at 95 citations.

Curated Papers

Key Challenges

Why It Matters

Optimizing pharmacotherapy reduces polypharmacy risks in elderly patients (Yermukhanova et al., 2023) and improves outcomes in chronic pancreatitis (Hayduchok et al., 2022). Adherence interventions enhance hypertension control (Shuper et al., 2020; Drapkina and Luishuta, 2017). Clinical pharmacist mediation boosts public health in cardiovascular care (Sulashvili et al., 2023), cutting healthcare costs amid rising chronic disease burdens.

Key Research Challenges

Patient Adherence Variability

Adherence differs by disease and demographics, complicating regimen optimization (Shuper et al., 2020; Ryvak et al., 2017). Self-reported measures overestimate compliance. Interventions must tailor to illness demands for efficacy.

Elderly Pharmacokinetic Changes

Age alters drug absorption, distribution, and metabolism, raising adverse effect risks (Yermukhanova et al., 2023). Polypharmacy exacerbates interactions. Dosing models require patient-specific adjustments.

Dosage Adjustment Modeling

Self-treatment demands dynamic dose simulations based on monitoring (Gelman, 2023). Real-world data from EHRs is noisy. Predictive models balance efficacy and safety in chronic conditions.

Essential Papers

Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.

Вікторія Шаповалова · 2022 · SSP Modern Pharmacy and Medicine · 95 citations

The COVID-19 pandemic has strained the healthcare system. It is important to consider forensic and pharmaceutical risks in the organization of vaccination practices and pharmacotherapy of covid, po...

Provision of Medication Therapy Management to University Faculty and Staff Members by Third-year Pharmacy Students

Heidi Eukel, Elizabeth Skoy, Jeanne E. Frenzel · 2010 · American Journal of Pharmaceutical Education · 26 citations

Chronic Pancreatitis, Comorbid with Alcohol Addiction: Epidemiology, Causes, Developmental Features, Symptoms and Supportive Pharmaceutical Therapy

Ihor Hayduchok, Iryna Tukhar, Валерій Шаповалов · 2022 · SSP Modern Pharmacy and Medicine · 19 citations

Chronic pancreatitis is a chronic inflammatory disease of the pancreas, which is accompanied by irreversible structural changes in the development of excretory and incretory insufficiency, manifest...

Organization of the Pharmaceutical Business, Drug Technology and Forensic Pharmacy: Modern Trends in The Development of the Science of Pharmaceutical Law During the Covid-19 Pandemic

T. M. Krasnianska, Mykola Ponomarenko · 2022 · SSP Modern Pharmacy and Medicine · 13 citations

The COVID-19 pandemic has affected modern trends in the training of doctors and pharmacists and their professional development. At the same time, the pandemic contributed to the development of the ...

Investigation of the level of adherence to treatment of patients with arterial hypertension

V. О. Shuper, S. V. Shuper, Yu. O. Rykova et al. · 2020 · Bukovinian Medical Herald · 2 citations

ДОСЛІДЖЕННЯ ПРИХИЛЬНОСТІ ДО ЛІКУВАННЯ ХВОРИХ НА АРТЕРІАЛЬНУ ГІПЕРТЕНЗІЮ В.О. Шупер 1 , С.В. Шупер 2 , Ю

Assessment of Drug Adherence Level According to the Patients’ Opinion: Results of Research in Lviv of Ukraine

Tetiana Ryvak, Khrystyna Makukh, Andriy Zimenkovsky · 2017 · Journal of Applied Pharmaceutical Science · 1 citations

Poor adherence of chronic diseases treatment is a worldwide problem, in Ukraine as well.Improving adherence also enhances patients' safety.Consequently, interventions that target adherence must be ...

THE DISCLOSURE OF FEATURES, CHARACTERISTICS, POSSIBILITIES AND SPECIALTIES OF CLINICAL PHARMACISTS AS MEDIATOR AMONG DOCTORS AND PATIENTS FOR ENHANCEMENT PUBLIC HEALTH SECTOR IN A GLOBAL WORLD

Nodar Sulashvili, Margarita Beglaryan, Nana Gorgaslidze et al. · 2023 · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · 1 citations

Collaboration between physicians and clinical pharmacists in the field of nursing is expanding and showing positive results. In recent decades, research has focused on cardiovascular disease in pri...

Reading Guide

Foundational Papers

Start with Eukel et al. (2010, 26 citations) for medication therapy management basics by pharmacy students, establishing patient-specific optimization protocols.

Recent Advances

Study Шаповалова (2022, 95 citations) for COVID pharmacotherapy risks; Gelman (2023) for self-treatment dosing models; Yermukhanova et al. (2023) for elderly features.

Core Methods

Adherence surveys (Shuper et al., 2020); PK/PD simulations (Gelman, 2023); clinical pharmacist collaboration (Sulashvili et al., 2023); real-practice synergy studies (Drapkina and Luishuta, 2017).

How PapersFlow Helps You Research Pharmacotherapy Optimization

Discover & Search

Research Agent uses searchPapers and exaSearch to find adherence studies like Shuper et al. (2020), then citationGraph reveals connections to Ryvak et al. (2017), and findSimilarPapers uncovers related hypertension optimization papers.

Analyze & Verify

Analysis Agent applies readPaperContent to extract pharmacokinetic data from Gelman (2023), verifies claims with CoVe against Eukel et al. (2010), and runs PythonAnalysis for adherence rate statistics using pandas on trial data, with GRADE grading for evidence strength in therapy management.

Synthesize & Write

Synthesis Agent detects gaps in elderly dosing (Yermukhanova et al., 2023) and flags contradictions in COVID pharmacotherapy (Шаповалова, 2022), while Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to draft regimen protocols with exportMermaid for PK/PD flowcharts.

Use Cases

"Analyze adherence rates in hypertension papers and plot trends"

Research Agent → searchPapers('hypertension adherence') → Analysis Agent → readPaperContent(Shuper 2020) + runPythonAnalysis(pandas plot of rates from Ryvak 2017) → matplotlib trend graph output.

"Write LaTeX review on COVID pharmacotherapy optimization"

Synthesis Agent → gap detection(Шаповалова 2022 + Hayduchok 2022) → Writing Agent → latexEditText(draft) → latexSyncCitations(Eukel 2010) → latexCompile → PDF with citations.

"Find code for dosage adjustment models in chronic disease papers"

Research Agent → searchPapers('dosage modeling chronic') → Code Discovery → paperExtractUrls(Gelman 2023) → paperFindGithubRepo → githubRepoInspect → PK simulation scripts.

Automated Workflows

Deep Research workflow scans 50+ papers on adherence (Shuper et al., 2020 chain), generating structured reports with GRADE scores. DeepScan applies 7-step verification to COVID therapy risks (Шаповалова, 2022), checkpointing PK claims. Theorizer builds dosing theories from Gelman (2023) self-treatment models.

Try Doxa for Pharmacotherapy Optimization Research

Frequently Asked Questions

What defines pharmacotherapy optimization?

It refines drug dosing, combinations, and regimens via PK modeling and adherence strategies to boost efficacy and cut adverse effects (Gelman, 2023; Eukel et al., 2010).

What methods improve patient adherence?

Tailored interventions address illness demands, assessed via surveys (Ryvak et al., 2017; Shuper et al., 2020). Clinical pharmacists mediate (Sulashvili et al., 2023).

What are key papers?

Шаповалова (2022, 95 citations) on COVID risks; Eukel et al. (2010, 26 citations) on therapy management; Hayduchok et al. (2022) on pancreatitis support.

What open problems exist?

Dynamic self-dosing models for chronic diseases (Gelman, 2023); elderly PK adjustments (Yermukhanova et al., 2023); real-world polypharmacy data integration.